Source:http://linkedlifedata.com/resource/pubmed/id/19420134
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2009-9-1
|
pubmed:abstractText |
Clinical translation of dendritic cell (DC)-based cell therapy requires preclinical studies in nonhuman primates (NHPs). The aim of this work was to establish the in vitro conditions for generation of NHP tolerogenic DCs (Tol-DCs), as well as to analyze the molecular mechanisms by which these cells could control an immune response. Two populations of NHP bone marrow-derived DCs (BMDCs) were obtained: adherent and nonadherent. Although both populations displayed a quite similar phenotype, they were very different functionally. We characterized the adherent BMDCs as Tol-DCs that were poor stimulators of T cells and actively inhibited T-cell proliferation, whereas the nonadherent population displayed immunogenic properties in vitro. Interestingly, the anti-inflammatory and immunosuppressive enzyme heme oxygenase-1 (HO-1) was up-regulated in Tol-DCs, compared to the immunogenic BMDCs. We demonstrated that HO-1 mediates the immunosuppressive properties of Tol-DCs in vitro (in NHPs and rats) and that HO-1 is involved in the in vivo tolerogenic effect of Tol-DCs in a rat model of allotransplantation. In conclusion, here we characterized the in vitro generation of NHP Tol-DCs. Furthermore, we showed for the first time that HO-1 plays a role in the active inhibition of T-cell responses by rat and NHP Tol-DCs.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1530-6860
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3070-7
|
pubmed:meshHeading |
pubmed-meshheading:19420134-Animals,
pubmed-meshheading:19420134-Bone Marrow Cells,
pubmed-meshheading:19420134-Cell Adhesion,
pubmed-meshheading:19420134-Cell Transplantation,
pubmed-meshheading:19420134-Cells, Cultured,
pubmed-meshheading:19420134-Dendritic Cells,
pubmed-meshheading:19420134-Heme Oxygenase-1,
pubmed-meshheading:19420134-Immune Tolerance,
pubmed-meshheading:19420134-Primates,
pubmed-meshheading:19420134-Rats,
pubmed-meshheading:19420134-T-Lymphocytes,
pubmed-meshheading:19420134-Transplantation, Homologous,
pubmed-meshheading:19420134-Up-Regulation
|
pubmed:year |
2009
|
pubmed:articleTitle |
Tolerogenic dendritic cells actively inhibit T cells through heme oxygenase-1 in rodents and in nonhuman primates.
|
pubmed:affiliation |
INSERM U643, CHU Hotel-Dieu, Nantes, France.
|
pubmed:publicationType |
Journal Article
|